Cardiovascular Systems Ownership
Cardiovascular Systems holds a total of 42.2 Million outstanding shares. The majority of Cardiovascular Systems outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Cardiovascular Systems to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Cardiovascular Systems. Please pay attention to any change in the institutional holdings of Cardiovascular Systems as this could imply that something significant has changed or is about to change at the company. On April 19, 2023, Senator Tina Smith of US Senate acquired $50k to $100k worth of Cardiovascular Systems's common stock.
Some institutional investors establish a significant position in stocks such as Cardiovascular Systems in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Cardiovascular Systems, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
Cardiovascular |
Cardiovascular Stock Ownership Analysis
About 90.0% of the company shares are held by institutions such as insurance companies. The book value of Cardiovascular Systems was currently reported as 5.7. The company has Price/Earnings (P/E) ratio of 724.24. Cardiovascular Systems recorded a loss per share of 0.96. The entity had not issued any dividends in recent years. The firm had 1:10 split on the 26th of February 2009. Cardiovascular Systems, Inc., a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. Cardiovascular Systems, Inc. was founded in 1989 and is headquartered in Saint Paul, Minnesota. Cardiovascular Syst operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 725 people. For more info on Cardiovascular Systems please contact the company at 651 259 1600 or go to https://www.csi360.com.Cardiovascular Systems Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Cardiovascular Systems insiders, such as employees or executives, is commonly permitted as long as it does not rely on Cardiovascular Systems' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Cardiovascular Systems insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Scott Ward over a year ago Disposition of 578310 shares by Scott Ward of Cardiovascular Systems subject to Rule 16b-3 |
Cardiovascular Systems' latest congressional trading
Congressional trading in companies like Cardiovascular Systems, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in Cardiovascular Systems by those in governmental positions are based on the same information available to the general public.
| 2023-04-19 | Senator Tina Smith | Acquired $50K to $100K | Verify |
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Consideration for investing in Cardiovascular Stock
If you are still planning to invest in Cardiovascular Systems check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cardiovascular Systems' history and understand the potential risks before investing.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |